Pressure Ulcers Treatment Market Report by Ulcer Type, Product Type, End User, and Region 2024-2032
세계 욕창 치료 시장 규모는 2023년 53억 달러에 달했습니다. 향후 IMARC Group은 2032년까지 시장 규모가 80억 달러에 달해 2024-2032년 사이 4.52%의 연평균 성장률(CAGR)을 기록할 것으로 예상하고 있습니다.
욕창(욕창)이라고도 불리는 욕창은 피부에 대한 장기간의 압박과 전단력으로 인한 피부와 하부 조직의 퇴행성 손상입니다. 욕창은 보통 등, 엉덩이, 꼬리뼈, 발뒤꿈치, 팔꿈치, 어깨, 발목 등 신체의 뼈와 근육 부위에 발생합니다. 특히 감각 장애, 영양실조, 동반 질환, 장시간 부동 등이 있는 집단에서는 이환율과 사망률이 높습니다. 욕창은 근육과 뼈가 노출된 깊은 분화구를 예방하기 위한 적절한 예방 조치와 약물 요법으로 치료할 수 있습니다. 욕창 치료에는 괴사 조직 제거, 환부 피부의 압력 감소, 상처 관리, 통증 조절, 상처 치유를 위한 좋은 영양 상태와 습윤 환경 유지 등이 포함됩니다. 또한, 일반적인 식염수로 상처를 세척하고 감염된 부위에 적절한 드레싱 재료를 사용하는 것도 필요합니다. 이 외에도 궤양을 조기에 발견하고 치료하면 뼈와 관절 감염, 봉와직염, 패혈증, 암과 같은 합병증의 위험을 최소화할 수 있습니다.
욕창 치료 시장 동향
피부 취약성, 세포층이 얇아지고 모세혈관 밀도 및 세포 증식 저하로 인해 욕창이 발생하기 쉬운 전 세계 노인 인구의 증가는 시장에 긍정적인 영향을 미치는 주요 요인 중 하나입니다. 또한, 비만과 만성질환의 증가로 인해 욕창이 급증하고 있습니다. 이와는 별도로, 욕창의 조기 진단과 치료의 용이성에 대한 개인의 인식이 높아진 것도 시장 성장에 기여하고 있습니다. 또한, 병원, 클리닉, 약국, 약국 및 약국의 확대와 의료 산업에서 기술 발전의 채택은 시장 전망을 밝게 하고 있습니다. 또한, 시장 선도 기업들이 새로운 상처 관리 제품 처방에 집중하기 시작한 것도 시장을 견인할 것으로 예상됩니다.
본 보고서에서 다루는 주요 질문들
- 세계 욕창 치료 시장은 지금까지 어떻게 성장해왔고, 앞으로 어떻게 변화할 것인가?
- COVID-19는 세계 욕창 치료 시장에 어떤 영향을 미쳤을까?
- 주요 지역 시장이란?
- 궤양 유형별 시장 현황은?
- 제품 유형별 시장 분석은?
- 최종사용자별 시장 분석은?
- 산업 가치사슬의 다양한 단계는 무엇인가?
- 업계의 주요 촉진요인과 과제는 무엇인가?
- 세계 욕창 치료 시장의 구조와 주요 진출 기업은?
- 업계의 경쟁은 어느 정도인가?
목차
제1장 서문
제2장 조사 범위와 조사 방법
- 조사 목적
- 이해관계자
- 데이터 소스
- 시장 추정
- 조사 방법
제3장 주요 요약
제4장 소개
제5장 세계의 욕창 치료 시장
- 시장 개요
- 시장 실적
- COVID-19의 영향
- 시장 예측
제6장 시장 내역 : 궤양 유형별
- 스테이지 1
- 스테이지 2
- 스테이지 3
- 스테이지 4
제7장 시장 내역 : 제품 유형별
제8장 시장 내역 : 최종사용자별
제9장 시장 내역 : 지역별
- 북미
- 아시아태평양
- 유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 러시아
- 기타
- 라틴아메리카
- 중동 및 아프리카
제10장 SWOT 분석
제11장 밸류체인 분석
제12장 Porter's Five Forces 분석
- 개요
- 구매자의 교섭력
- 공급 기업의 교섭력
- 경쟁 정도
- 신규 참여업체의 위협
- 대체품의 위협
제13장 가격 분석
제14장 경쟁 상황
- 시장 구조
- 주요 기업
- 주요 기업 개요
- 3M Company
- Arjo AB
- B. Braun Melsungen AG(B. Braun Holding GmbH & Co. KG)
- Cardinal Health Inc.
- Coloplast A/S
- Hill-Rom Holdings Inc.(Baxter International Inc.)
- Invacare Corporation
- Molnlycke Health Care AB
- Smith & Nephew plc
- Span America(UTi Worldwide Inc.)
- Stiegelmeyer GmbH & Co. KG
- Stryker Corporation
ksm
The global pressure ulcers treatment market size reached US$ 5.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.0 Billion by 2032, exhibiting a growth rate (CAGR) of 4.52% during 2024-2032.
Pressure ulcers, also known as bedsores, are degenerative skin and underlying tissue injuries caused by prolonged pressure and shearing forces on the skin. They usually affect the bony and muscle areas of the body, such as back, buttocks, tailbone, heels, elbow, shoulder, and ankles. They lead to morbidity and mortality, especially among the masses with impaired sensation, poor nutrition, comorbidities, and prolonged immobility. They are cured by appropriate preventive measures and medications that help prevent deep craters with exposed muscle and bone. Pressure ulcers treatment involves removing necrotic tissue, reducing pressure on the affected skin, caring for wounds, controlling pain, and maintaining good nutrition and a moist environment for wound healing. It also involves wound cleansing with normal saline and appropriate dressings for the infected area. Besides this, early identification and treatment of these ulcers minimize the risk of complications, including bone and joint infections, cellulitis, sepsis, and cancer.
Pressure Ulcers Treatment Market Trends:
The increasing global geriatric population, which is more susceptible to developing pressure ulcers due to skin fragility and thinning of the cell layers and decreased capillary density and cell growth represents one of the key factors positively influencing the market. In addition, the increasing prevalence of obesity and chronic medical diseases is resulting in the surging occurrence of pressure ulcers. Apart from this, the rising awareness among individuals about the early diagnosis of bedsores, along with the easy availability of treatment, is also contributing to the market growth. Furthermore, the expansion of hospitals, clinics, pharmacies, and drug stores, coupled with the introduction of technological advancements in the healthcare industry, is creating a positive market outlook. Additionally, the rising focus of leading market players on the formulation of novel wound care products is anticipated to drive the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global pressure ulcers treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on ulcer type, product type and end user.
Breakup by Ulcer Type:
Stage 1
Stage 2
Stage 3
Stage 4
Breakup by Product Type:
Wound-Care Dressings
Wound-Care Devices
Others
Breakup by End User:
Hospitals
Clinics
Ambulatory Surgical Centers
Homecare Settings
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Arjo AB, B. Braun Melsungen AG (B. Braun Holding GmbH & Co. KG), Cardinal Health Inc., Coloplast A/S, Hill-Rom Holdings Inc. (Baxter International Inc.), Invacare Corporation, Molnlycke Health Care AB, Smith & Nephew plc, Span America (UTi Worldwide Inc.), Stiegelmeyer GmbH & Co. KG and Stryker Corporation.
Key Questions Answered in This Report:
- How has the global pressure ulcers treatment market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global pressure ulcers treatment market?
- What are the key regional markets?
- What is the breakup of the market based on the ulcer type?
- What is the breakup of the market based on the product type?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global pressure ulcers treatment market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Pressure Ulcers Treatment Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Ulcer Type
- 6.1 Stage 1
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Stage 2
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Stage 3
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Stage 4
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Product Type
- 7.1 Wound-Care Dressings
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Wound-Care Devices
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Others
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Clinics
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Ambulatory Surgical Centers
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Homecare Settings
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 3M Company
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Arjo AB
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.3 B. Braun Melsungen AG (B. Braun Holding GmbH & Co. KG)
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 SWOT Analysis
- 14.3.4 Cardinal Health Inc.
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Coloplast A/S
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Hill-Rom Holdings Inc. (Baxter International Inc.)
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 SWOT Analysis
- 14.3.7 Invacare Corporation
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Molnlycke Health Care AB
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 SWOT Analysis
- 14.3.9 Smith & Nephew plc
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Span America (UTi Worldwide Inc.)
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.11 Stiegelmeyer GmbH & Co. KG
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.12 Stryker Corporation
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.12.3 Financials
- 14.3.12.4 SWOT Analysis
